Action is essential, both mid-term and more immediately, to improve the implementation of the EU’s medtech regulations and to find a better way forward as the “EU is not where it should be.”
That is the view of Petra Zoellner, director regulatory affairs (IVDR and MDR) at MedTech Europe while speaking with